Total Valuation
Orthofix Medical has a market cap or net worth of €352.89M. The enterprise value is €531.38.
Market Cap€352.89M
Enterprise Value€531.38
Share Statistics
Orthofix Medical has 40,732,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,732,610
Owned by Insiders25.74%
Owned by Institutions9.76%
Financial Efficiency
Orthofix Medical’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -10.01%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-10.01%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee512.34K
Profits Per Employee-57.44K
Employee Count1,605
Asset Turnover0.97
Inventory Turnover7.92
Valuation Ratios
The current PE Ratio of Orthofix Medical is ―. Orthofix Medical’s PEG ratio is 0.22.
PE Ratio―
PS Ratio0.74
PB Ratio1.34
Price to Fair Value1.34
Price to FCF-472.73
Price to Operating Cash Flow25.14
PEG Ratio0.22
Income Statement
In the last 12 months, Orthofix Medical had revenue of 822.31M and earned -92.19M in profits. Earnings per share was -2.28.
Revenue822.31M
Gross Profit551.71M
Operating Income-68.47M
Pretax Income-90.81M
Net Income-92.19M
EBITDA-22.35M
Earnings Per Share (EPS)-2.28
Cash Flow
In the last 12 months, operating cash flow was 17.05M and capital expenditures -44.08M, giving a free cash flow of -27.03M billion.
Operating Cash Flow17.05M
Free Cash Flow-27.03M
Free Cash Flow per Share-0.66
Dividends & Yields
Orthofix Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-31.15%
50-Day Moving Average8.96
200-Day Moving Average10.62
Relative Strength Index (RSI)42.22
Average Volume (3m)0.00
Important Dates
Orthofix Medical upcoming earnings date is Nov 11, 2026, After Close (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Orthofix Medical as a current ratio of 2.45, with Debt / Equity ratio of 54.67%
Current Ratio2.45
Quick Ratio2.24
Debt to Market Cap0.31
Net Debt to EBITDA-6.59
Interest Coverage Ratio-3.92
Taxes
In the past 12 months, Orthofix Medical has paid 1.38M in taxes.
Income Tax1.38M
Effective Tax Rate-0.02
Enterprise Valuation
Orthofix Medical EV to EBITDA ratio is -33.64, with an EV/FCF ratio of -587.85.
EV to Sales0.91
EV to EBITDA-33.64
EV to Free Cash Flow-587.85
EV to Operating Cash Flow22.55
Balance Sheet
Orthofix Medical has €103.81M in cash and marketable securities with €234.62M in debt, giving a net cash position of -€130.81M billion.
Cash & Marketable Securities€103.81M
Total Debt€234.62M
Net Cash-€130.81M
Net Cash Per Share-€3.21
Tangible Book Value Per Share€4.57
Margins
Gross margin is 69.59%, with operating margin of -8.33%, and net profit margin of -11.21%.
Gross Margin69.59%
Operating Margin-8.33%
Pretax Margin-11.04%
Net Profit Margin-11.21%
EBITDA Margin-2.72%
EBIT Margin-8.92%
Analyst Forecast
The average price target for Orthofix Medical is €11.28, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€11.28
Price Target Upside7.43% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-4.02%
EPS Growth Forecast55.60%